The University Hospitals of Leicester NHS Trust (UHL) and Ergéa have opened UHL’s latest state-of-the-art Halcyon linear accelerator (linac).
This development aims to boost treatment capacity. ensuring patients have access to cutting-edge cancer care.
Ergéa UK has partnered with UHL since 2002.
Through the long-term partnership, Ergéa has supported UHL in delivering innovative healthcare by maintaining and upgrading Diagnostic Imaging, Cardiology and Radiotherapy equipment.
Last year an upgrade of UHL’s radiotherapy fleet was undertaken and by July 2024, all linacs at UHL – 4 truebeams – were modernised, ensuring efficient and reliable treatment delivery.
A key factor in the success of this project was the integration of new equipment across the fleet.
Both UHL and Ergéa teams worked to ensure compatibility among the linacs, which enabled consistent and reliable treatment replication between machines.
This collaboration significantly reduced treatment variation, enhancing the overall treatment environment and improving the patient experience.
Jon Melbourne, Chief Operating Officer at University Hospitals of Leicester, said: “We’re incredibly proud of the radiotherapy services we provide and the dedication of our teams.
“We’d also like to express our thanks to Ergéa for their flexibility and support throughout the programme – their partnership has been crucial to the success of this project.”
David Rolfe, CEO of Ergéa UK, added: “We are incredibly proud of our long-standing partnership with UHL, having worked closely with them for over 20 years.
“We are proud to be a trusted partner to UHL for so long, and we remain committed to delivering tailored solutions that benefit both patients and the wider community.
“Through a Managed Services approach, we provide capital investment, access to state-of-the-art equipment, and lifecycle optimisation, all designed to enhance the patient pathway.”
